John Dobak - Mar 9, 2023 Form 4/A - Amendment Insider Report for DermTech, Inc. (DMTK)

Role: Chief Executive Officer, Director
Signature: /s/ Mo Tashakor, attorney-in-fact
Stock symbol: DMTK
Transactions as of: Mar 9, 2023
Transactions value $: -$5,082
Form type: 4/A - Amendment
Date filed: 4/6/2023, 08:08 PM
Date Of Original Report: Mar 13, 2023
Previous filing: Mar 9, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DMTK	Common Stock	Award	$0	+56.4K	+8.76%	$0.00	700K	Mar 9, 2023	Direct	F1
transaction	DMTK	Common Stock	Sale	-$5.08K	-1.56K	-0.22%	$3.26	699K	Mar 13, 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Footnote No. 1 in the Form 4 originally filed on March 13, 2023 contained an error regarding the vesting schedule of the restricted stock units awarded to the reporting person. Footnote No. 1 is hereby corrected as follows: The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan and the terms of a Transition Agreement, dated March 1, 2023, between the reporting person and the issuer. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, (i) one-third (1/3) of the restricted stock units shall vest on June 5, 2023 and (ii) the remaining two-thirds (2/3) shall vest in two (2) equal installments of one-third (1/3) on the fifth day of each third month following June 5, 2023 until the final vesting date on December 5, 2023.
F2	The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on June 25, 2020.

Content

Footnote No. 1 in the Form 4 originally filed on March 13, 2023 contained an error regarding the vesting schedule of the restricted stock units awarded to the reporting person. Footnote No. 1 is hereby corrected as follows: The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan and the terms of a Transition Agreement, dated March 1, 2023, between the reporting person and the issuer. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, (i) one-third (1/3) of the restricted stock units shall vest on June 5, 2023 and (ii) the remaining two-thirds (2/3) shall vest in two (2) equal installments of one-third (1/3) on the fifth day of each third month following June 5, 2023 until the final vesting date on December 5, 2023.

The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on June 25, 2020.